Archives

Murphy USA: RIN Revenue More Than Doubles To $124.8 Million As Fuel Contribution Jumps 32%

By Amit Chowdhry ● Aug 11, 2026

Murphy USA's revenue from renewable identification numbers more than doubled during the second quarter of 2026 to $124.8 million from $59.8 million as stronger fuel margins and higher volumes drove a 32% increase in total fuel contribution.

Team8 Raises $365 Million For AI-Native Enterprise Investments As AUM Nears $2 Billion

By Amit Chowdhry ● Aug 11, 2026

Team8 has raised $365 million in new capital to invest in the next generation of AI-native enterprise companies, bringing the venture firm's total assets under management to nearly $2 billion across eight funds. The new capital includes $265 million for Team8 Capital's third fund and more than $100 million reserved for follow-on investments in portfolio companies where the firm has the highest conviction.

ZipRecruiter: $294.6 Million Debt Repurchase At $65 Million Discount Drives Major Balance-Sheet Reset

By Amit Chowdhry ● Aug 11, 2026

ZipRecruiter repurchased $294.6 million of senior unsecured notes during the second quarter of 2026 at a $65 million discount to par value, significantly reducing its debt burden while preserving liquidity as the employment marketplace increases its use of artificial intelligence.

Legio Raises $5 Million Seed Round From Klass Capital To Modernize Campus Public Safety

By Amit Chowdhry ● Aug 11, 2026

Legio has raised $5 million in seed funding from Klass Capital to build an AI-native safety and security operations platform designed specifically for colleges and universities.

Epicrispr Biotechnologies Raises $90 Million Series C To Advance Epigenetic Therapy EPI-321

By Amit Chowdhry ● Aug 11, 2026

Epicrispr Biotechnologies has closed an oversubscribed $90 million Series C financing to advance EPI-321 toward pivotal clinical development for facioscapulohumeral muscular dystrophy, or FSHD.

Infinimmune Raises $75 Million Series A To Advance Human-Derived Antibody Pipeline

By Amit Chowdhry ● Aug 11, 2026

Infinimmune has raised $75 million in Series A financing to advance a pipeline of fully human antibody therapeutics for atopic dermatitis and other inflammatory diseases. The round was co-led by Regeneron Ventures and Playground Global, with participation from RA Capital Management, Goldcrest Capital, Forge Life Science Partners, Godfrey Capital and Wild Tree Ventures. Existing investors Merck Global Health Innovation Fund, Everbright Biofund, Civilization Ventures and Pear VC also participated.

Versa Vascular Expands Series C To $42 Million And Appoints Bill Shields As CEO

By Amit Chowdhry ● Aug 11, 2026

Versa Vascular has expanded its Series C financing to $42 million and appointed longtime Medtronic structural heart executive Bill Shields as chief executive officer.

Omega Ophthalmics Raises $7 Million Series A To Advance Gemini Refractive Capsule Toward FDA Approval

By Amit Chowdhry ● Aug 11, 2026

Omega Ophthalmics has raised $7 million in Series A financing to advance its Gemini Refractive Capsule, a next-generation implant technology designed for cataract surgery. The round was led by a group of strategically aligned ultra-high-net-worth investors.

Global Engine Group And Angkasa-X Partner On Space-to-AI Edge Infrastructure Platform In Malaysia

By Amit Chowdhry ● Aug 11, 2026

Global Engine Group Holding Limited (GLE) and Angkasa-X Holdings Corp. have entered into a strategic collaboration agreement to jointly advance a “Space-to-AI” digital infrastructure platform in Sarawak, Malaysia.

Dermata Therapeutics: First Commercial Launch Arrives With $4.4 Million Cash And Runway Into Q4

By Amit Chowdhry ● Aug 11, 2026

Dermata Therapeutics is preparing to launch its first commercial product, Tome Foundational Treatment, on August 25, 2026, as the company completes a strategic transformation from pharmaceutical development into a commercial-stage, direct-to-consumer skincare business.

Accel Raises $3.5 Billion To Invest In Emerging Global AI Startups

By Amit Chowdhry ● Aug 11, 2026

Accel has raised $3.5 billion in new capital to invest in emerging technology companies around the world, expanding the venture capital firm's firepower as artificial intelligence continues to reshape the startup market, according to Bloomberg.

SINTX Technologies: Revenue Surges 199% As SiNAPTIC Foot And Ankle Commercialization Expands

By Amit Chowdhry ● Aug 11, 2026

SINTX Technologies reported a 199% year-over-year increase in second-quarter 2026 revenue as the advanced ceramics and medical technology company expands commercialization of its FDA-cleared SiNAPTIC Foot & Ankle Osteotomy Wedge System and pursues additional medical and industrial applications for its silicon nitride technology.

PDS Biotech Prioritizes PDS0301 After 71% Response Rate In Colorectal Cancer And Discontinues PDS0101 Phase 3 Trial

By Amit Chowdhry ● Aug 11, 2026

PDS Biotechnology has announced a strategic refocus that will prioritize development of PDS0301, its tumor-targeted immunocytokine, while discontinuing further internal investment in the Phase 3 VERSATILE-003 trial of PDS0101 and pursuing strategic partnerships or other externally funded opportunities for that program.

Google Gemini App Surpasses 1 Billion Monthly Users As Voice, Images, And Automation Drive Growth

By Amit Chowdhry ● Aug 11, 2026

Google's Gemini app has surpassed 1 billion monthly users, with the company describing it as the fastest-growing product in Google's history. Google said the milestone reflects increasing use of Gemini across voice interactions, real-time visual assistance, education, content creation and automated tasks across third-party applications.

K2 Global Raises $200 Million In Capital Commitments To Invest In AI And Frontier Technology Companies

By Amit Chowdhry ● Aug 11, 2026

K2 Global, the venture capital firm founded by solo investor Ozi Amanat, has secured $200 million in capital commitments to invest in artificial intelligence and other frontier technology sectors. The capital is focused on AI, robotics, compute infrastructure, semiconductors, national security and next-generation healthcare technologies.

Synaptics: Core IoT Sales Surge 43% To $390 Million And Reach One-Third Of Total Revenue

By Amit Chowdhry ● Aug 11, 2026

Synaptics' Core IoT business continued to become a substantially larger part of the semiconductor company's revenue mix during fiscal 2026, with product sales surging 43% year-over-year to approximately $389.7 million and representing 33% of total company sales.

Williams: $5.34 Billion Blackstone JV And $5.5 Billion Momentum Deal Accelerate LNG And Power Infrastructure Buildout

By Amit Chowdhry ● Aug 11, 2026

Williams is accelerating its natural gas and power infrastructure expansion through two major capital initiatives, including a Power Innovation joint venture with Blackstone that provides $5.34 billion of low-cost capital and an agreement to acquire Momentum Midstream for up to $5.5 billion.

Warby Parker: $14.4 Million Tariff Refund Helps Fund Google Gemini Eyewear Launch As Guidance Excludes New Product Revenue

By Amit Chowdhry ● Aug 11, 2026

Warby Parker expects a $14.4 million full-year tariff refund benefit that is being used partly to offset strategic investments ahead of the company's first Intelligent Eyewear collection, which combines Warby Parker frames with Google Gemini technology.

WPP: £500 Million Cost Savings Target And £200 Million Asset Sales Back Agentic AI Transformation

By Amit Chowdhry ● Aug 11, 2026

WPP is targeting £500 million of gross annualized cost savings by 2028 and more than £200 million of asset-sale proceeds during 2026 as the advertising company restructures around a more integrated operating model powered by its WPP Open agentic marketing platform.

Cardinal Health: Adjusted Free Cash Flow Nearly Doubles To $5 Billion As Buyback Authorization Reaches $6.4 Billion

By Amit Chowdhry ● Aug 11, 2026

Cardinal Health generated approximately $5 billion of adjusted free cash flow in fiscal 2026, nearly double the prior-year level, as strong operating performance provided the healthcare company with substantially greater capacity for share repurchases and other capital allocation priorities.

Equinox Gold: Valentine Expansion Targets 223,000 Ounces Annually As Orla Merger Creates 1.1 Million-Ounce Producer

By Amit Chowdhry ● Aug 11, 2026

Equinox Gold has approved the Phase 2 expansion of its Valentine mine as its completed combination with Orla Mining creates a gold producer expected to generate approximately 1.1 million ounces on a full-year pro forma basis in 2026.

Coeur Mining: Cash Nears 10x Year-Ago Level At $1.1 Billion As Free Cash Flow Surges 165%

By Amit Chowdhry ● Aug 11, 2026

Coeur Mining ended the second quarter of 2026 with $1.1 billion of cash, nearly 10 times its balance a year earlier and twice its year-end 2025 cash position, as free cash flow surged 165% year-over-year.

Advanced Drainage Systems: NDS Adds $94.7 Million Of Sales As Adjusted EBITDA Margin Expands To 35.8%

By Amit Chowdhry ● Aug 11, 2026

Advanced Drainage Systems' acquisition of National Diversified Sales contributed $94.7 million of revenue during the first quarter of fiscal 2027 as the water-management company increased total sales 20.6% and expanded its Adjusted EBITDA margin by approximately 230 basis points.

Xponential Fitness: 67 Gross New Studios Open As 53 Franchise Licenses Are Sold

By Amit Chowdhry ● Aug 11, 2026

Xponential Fitness continued expanding its boutique fitness network during the second quarter of 2026, opening 67 gross new studios and selling 53 franchise licenses despite weaker same-store sales and lower overall revenue.

Biohaven: Graves’ Autoantibodies Fall More Than 80% As Extracellular Protein Degrader Enters Phase 3

By Amit Chowdhry ● Aug 11, 2026

Biohaven's extracellular protein degradation platform has moved into pivotal development after BHV-1300 produced greater than 80% mean reductions in disease-driving autoantibodies in patients with Graves' disease.

Sana Biotechnology: Insulin-Producing Cells Survive 14 Months Without Immunosuppression As Mayo Clinic Invests $25 Million

By Amit Chowdhry ● Aug 11, 2026

Sana Biotechnology reported that transplanted insulin-producing pancreatic cells remained alive and functional 14 months after treatment in a patient with type 1 diabetes without the use of immunosuppression, as the company prepares to advance a related cell therapy into clinical testing.

CoreWeave Closes $2.6 Billion Loan Facility Arranged By JPMorgan And MUFG For AI Infrastructure

By Amit Chowdhry ● Aug 11, 2026

CoreWeave has closed a $2.6 billion delayed draw term loan facility to finance additional AI infrastructure and committed customer deployments. The facility, known as DDTL 5.5, expands CoreWeave’s high-performance computing infrastructure-backed financing platform by allowing a broader range of customer contracts to support syndicated infrastructure financing.

LPL Financial Expands Wealth Management Platform As HNW And UHNW Assets Top $300 Billion

By Amit Chowdhry ● Aug 11, 2026

LPL Financial is expanding its wealth management platform with new capabilities across investment management, alternative investments, tax planning, banking, lending and high-net-worth services as the firm looks to help advisors deliver more comprehensive financial advice.

Neros Raises $250 Million Series C At $2.5 Billion Valuation To Scale Autonomous And Interceptor Drone Programs

By Amit Chowdhry ● Aug 11, 2026

Neros Technologies has raised $250 million in Series C funding at a $2.5 billion post-money valuation to accelerate development and production of its autonomous and interceptor drone programs. The round was co-led by Sequoia Capital and American Strategic Technology Fund, with participation from Interlagos, Valor Equity Partners, Allen & Company, Thiel Capital, Spark Capital and Dylan Field.

New York Yankees Secures $2.6 Billion Financing From Apollo Sports Capital

By Amit Chowdhry ● Aug 11, 2026

Yankee Global Enterprises, the holding company of the New York Yankees, has entered into a $2.6 billion financing agreement with affiliates of Apollo Sports Capital. The financing combines credit and equity and is intended to support continued growth of the Yankees franchise while refinancing existing debt.